ArticleScientific reports2026
DFT calculation of Ac
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The stability constant (logK1) and reactivity are ultimately the most crucial components to consider during the evaluation and selection of chelators to match with a specific radiometal ion for usage in radiopharmaceutical applications. These components evaluate the thermodynamic stability of the radiometal-chelator complex. Additionally, the effectiveness of chelator in binding with radiometal ions with relatively large atomic radii (e.g., 213Bi3+ and 225Ac3+) coupled with charge-diffuse properties result in weaker metal-ligand interactions, and this poses challenges in chelator development. The (2-[(carboxymethyl)]5-(4-nitrophenyl-1-[4,7,10-tris(carboxymethyl)-1,4,7,10-tPentan-2-yl) amino] acetic acid (3p-C-DEPA) is a new hybrid chelator designed for potential radio-complexation applications in radio-theranostics and preclinical data has shown great promise for this chelating ligand. Hence, this study investigates the stability constant and chemical reactivity descriptors of the complex generated between 3p-C-DEPA and the α-emitting radioisotopes 213Bi3+ and 225Ac3+ as well as the β-emitting particle 177Lu3+ for the first-time using density functional theory (DFT) calculations. The method employs two functional densities, MO6-HF and B3LYP, using the basis set 6-311G(d)/SDD, alongside the continuous solvation models SMD (solvation model density) and COSMO (conductor-like screening model). The interactions of all radiometals with the hybrid chelator 3p-C-DEPA are compared to the benchmark chelator, 1,4,7,10-tetrazacyclodecane-1,4,7,10-tetraacetic acid (DOTA), yielding comprehensive data on the stability constants and based structural features of radiometal-chelator complexes. DFT analysis has shown that the stability of the 3p-C-DEPA chelator complex formation is influenced by the atomic radius of the radiometal and the number of nitrogen and oxygen donors, proving to be effective for Ac3+ and Bi3+, in contrast to Lu3+, which shows lower stability constant values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.